Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
WASHINGTON — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical mainstream. The panel of advisers to the Food and Drug … Read more
